Evidence map›Paper›PMID 41952176›Full record

ArticleGenome medicine2026

Attention-based deep learning for analysis of pathology images and gene expression data in lung squamous premalignant lesions.

Lingyi Xu, Yohana Kefella, Yichi Zhang, Regan D Conrad, Kelley E Anderson, Kostyantyn Krysan, Gang Liu, Erin Kane, Adam Pennycuick, Daniel T Merrick and 7 more

Abstract read
In one paragraph

Article in Genome medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

17 authors.

Lingyi XuFaculty of Computing & Data Sciences, Boston University, Boston, MA, USA.
Yohana KefellaDepartment of Medicine, Boston University Chobanian & Avedisian School of Medicine, 72 E. Concord Street, Boston, MA, 02118, USA.
Yichi ZhangFaculty of Computing & Data Sciences, Boston University, Boston, MA, USA.
Regan D ConradDepartment of Medicine, Boston University Chobanian & Avedisian School of Medicine, 72 E. Concord Street, Boston, MA, 02118, USA.
Kelley E AndersonDepartment of Medicine, Boston University Chobanian & Avedisian School of Medicine, 72 E. Concord Street, Boston, MA, 02118, USA.
Kostyantyn KrysanDepartment of Medicine, David Geffen School of Medicine at UCLA, Los Angeles, CA, USA.
Gang LiuDepartment of Medicine, Boston University Chobanian & Avedisian School of Medicine, 72 E. Concord Street, Boston, MA, 02118, USA.
Erin KaneDepartment of Medicine, Boston University Chobanian & Avedisian School of Medicine, 72 E. Concord Street, Boston, MA, 02118, USA.
Adam PennycuickLungs for Living Research Centre, UCL Respiratory, University College London, London, UK.
Daniel T MerrickDepartement of Pathology, University of Colorado School of Medicine, Aurora, CO, USA.
Sam M JanesLungs for Living Research Centre, UCL Respiratory, University College London, London, UK.
Mary E ReidRoswell Park Comprehensive Cancer Center, Buffalo, NY, USA.
Eric J BurksDepartment of Pathology and Laboratory Medicine, Boston University Chobanian & Avedisian School of Medicine, Boston, MA, USA.
Ehab BillatosDepartment of Medicine, Boston University Chobanian & Avedisian School of Medicine, 72 E. Concord Street, Boston, MA, 02118, USA.
Sarah A MazzilliDepartment of Medicine, Boston University Chobanian & Avedisian School of Medicine, 72 E. Concord Street, Boston, MA, 02118, USA.
Vijaya B KolachalamaFaculty of Computing & Data Sciences, Boston University, Boston, MA, USA.
Jennifer E BeaneFaculty of Computing & Data Sciences, Boston University, Boston, MA, USA. jbeane@bu.edu.ORCID http://orcid.org/0000-0002-6699-2132

Funding

Project-005UL1TR001430 · NCATS · BOSTON UNIVERSITY MEDICAL CAMPUS · PI BAIR-MERRITT, MEGAN H, CENTER, DAVID M. · 2015 to 2024
$52.3M
The Lung PCA: A Multi-Dimensional Atlas of Pulmonary PremalignancyU2CCA233238 · NCI · BOSTON UNIVERSITY MEDICAL CAMPUS · PI DUBINETT, STEVEN M., SPIRA, AVRUM E · 2018 to 2021
$7.0M
Digital Cognitive Assessment of Preclinical Alzheimer's Disease and Related DementiasR01AG083735 · NIA · BOSTON UNIVERSITY MEDICAL CAMPUS · PI Rhoda Au, Vijaya B. Kolachalama · 2024 to 2026
$2.4M
Mechanisms of drug-coated balloon therapyR01HL159620 · NHLBI · BOSTON UNIVERSITY MEDICAL CAMPUS · PI KOLACHALAMA, VIJAYA B. · 2021 to 2024
$2.1M
Cognitive Heterogeneity in those with high Alzheimer's Disease RiskRF1AG062109 · NIA · BOSTON UNIVERSITY MEDICAL CAMPUS · PI AU, RHODA · 2020 to 2021
$1.8M
Digital Neurodegenerative Pathology After Repetitive Head ImpactsR01NS142076 · NINDS · BOSTON UNIVERSITY MEDICAL CAMPUS · PI Jonathan D Cherry, Vijaya B. Kolachalama · 2025 to 2026
$1.7M
Cognitive heterogeneity in those with high Alzheimer's Disease RiskR01AG062109 · NIA · BOSTON UNIVERSITY MEDICAL CAMPUS · PI Rhoda Au, Vijaya B. Kolachalama · 2025 to 2026
$1.6M
Cognitive heterogeneity in those with high Alzheimer's Disease RiskR56AG062109 · NIA · BOSTON UNIVERSITY MEDICAL CAMPUS · PI AU, RHODA · 2018 to 2018
$517k
PRISTINE: Pre-cancer histology identification of Endobronchial biopsies using deep learningR21CA253498 · NCI · BOSTON UNIVERSITY MEDICAL CAMPUS · PI BEANE, JENNIFER ELLEN, KOLACHALAMA, VIJAYA B. · 2020 to 2020
$424k
American Association for Cancer Research SU2C-AACR-DT23-17American Heart Association 20SFRN35460031Johnson and Johnson Innovation Sponsored Research AgreementNational Heart, Lung, and Blood Institute,United States R01-HL159620National Institute of Neurological Disorders and Stroke,United States R01-NS142076National Institute on Aging,United States R01-AG083735NCATS NIH HHS BU-CTSI Grant Number 1UL1TR001430NCATS NIH HHS UL1 TR001430NCI NIH HHS R21 CA253498NCI NIH HHS R21-CA253498NCI NIH HHS U2C CA233238NCI NIH HHS U2C-CA233238NHLBI NIH HHS R01 HL159620NIA NIH HHS R01 AG062109NIA NIH HHS R01- AG062109NIA NIH HHS R01 AG083735NIA NIH HHS R56 AG062109NIA NIH HHS RF1 AG062109NINDS NIH HHS R01 NS142076
6 · The paper itself

Abstract

backgroundMolecular and cellular alterations to the normal pseudostratified columnar bronchial epithelium results in the development of bronchial premalignant lesions representing a spectrum of histology from normal to hyperplasia, metaplasia, dysplasia (mild, moderate, and severe), carcinoma in situ and invasive carcinoma. Several studies have identified molecular alterations associated with lesion histology and progression. The broad and continuous spectrum of histologic and molecular changes makes reproducible stratification of lesions across multiple studies challenging.

methodsWe developed a transformer-based framework that flexibly utilizes transcriptomic and histologic patterns to distinguish lesions with bronchial dysplasia or worse from normal, hyperplasia, and metaplasia. We leveraged H&E whole slide images (WSIs) of endobronchial biopsies and bulk gene expression data (GE) derived from endobronchial biopsies and brushings from previously published studies and on-going lung precancer atlas efforts obtained from patients at high-risk for lung cancer.

resultsOn an external testing dataset of WSIs, the model trained on WSIs plus GE achieved an area under the ROC curve (AUROC) of 0.884 ± 0.040 compared to 0.829 ± 0.046 for the model trained on WSIs alone. On external testing datasets of GE, the model trained on WSIs plus GE achieved an AUROC of 0.857 ± 0.033 versus 0.713 ± 0.098 for a model trained on GE alone. Based on these results, we leveraged data across 4 studies to train a flexible fusion model that allows one or both data modalities (WSIs and GE) to be used in training. The model achieved an AUROC of 0.906 ± 0.034 on external testing WSIs data and 0.870 ± 0.023 on external testing GE data. Despite model training on a binary label, model probabilities were associated with histologic grade and the model identified gene expression alterations associated with bronchial dysplasia across multiple studies.

conclusionsOur multimodal transformer outperformed models trained on a single data modality and enabled the inclusion of samples with one or both modalities during training and/or testing. It increases the flexibility, scalability, and real-world applicability of disease severity assessment that better risk stratifies bronchial premalignant lesions even when only routine histology data is accessible.

Indexed as

Deep LearningImage Processing, Computer-AssistedLung NeoplasmsPrecancerous ConditionsGene Expression ProfilingGene Expression Regulation, NeoplasticHumansDeep learningDigital pathologyDysplasiaPremalignant

Identifiers

PMID41952176
PMCPMC13188385

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.